Aytu BioPharma, Inc. (AYTU) NASDAQ
2.20
-0.07(-3.08%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Aytu BioPharma, Inc.
Address
373 Inverness Parkway
Englewood, CO 80112
United States of America (the)
Phone
720 437 6580
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
102
First IPO Date
September 25, 2008
Key Executives
| Name | Title | Pay | Year Born |
| Joshua R. Disbrow | Chief Executive Officer & Director | 837,800 | 1975 |
| Ryan J. Selhorn | Chief Financial Officer, Corporate Secretary & Treasurer | 507,796 | 1982 |
| Greg Pyszczymuka | Chief Commercial Officer | 513,579 | 1979 |
| Jarrett T. Disbrow | Chief Business Officer | 540,750 | 1975 |
| Gerwin Westfield | Senior Vice President of Scientific Affairs | 0 | N/A |
| Margaret Cabano | Vice President of Operations | 0 | N/A |
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.
